Literature DB >> 23671534

Disappearance of a major thrombus in the brachiocephalic vein without anticoagulant therapy in a patient with seminoma: A case report.

Hiroshi Hongo1, Hiroki Ide, Katsura Hoshino, Yota Yasumizu, Yasumitsu Uchida, Takeshi Masuda.   

Abstract

This is the first case report describing brachiocephalic vein thrombosis without compression by a metastatic tumour during chemotherapy for testicular cancer. According to previous reports of testicular cancer patients with a major thrombus, anticoagulant therapy was required to resolve all cases. However, in the present case, a major thrombus in the brachiocephalic vein disappeared without anticoagulant therapy. This 42-year-old man was diagnosed with testicular seminoma and multiple metastases to the para-aortic lymph nodes. After 3 cycles of cisplatin, etoposide and bleomycin (PEB) therapy, a major thrombus in the right brachiocephalic vein was recognized on a computed tomography (CT) scan. Although no anticoagulant therapy was undertaken, the thrombus in the right brachiocephalic vein was no longer visible on CT after the fourth cycle of PEB therapy.

Entities:  

Year:  2013        PMID: 23671534      PMCID: PMC3650769          DOI: 10.5489/cuaj.545

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  11 in total

1.  Cancer-associated thrombosis.

Authors:  Rodger L Bick
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

Review 2.  Cancer and thrombosis: implications of published guidelines for clinical practice.

Authors:  A A Khorana
Journal:  Ann Oncol       Date:  2009-06-26       Impact factor: 32.976

3.  Thromboembolic events during combination chemotherapy for germ cell-malignancy.

Authors:  B M Cantwell; K A Mannix; J T Roberts; S E Ghani; A L Harris
Journal:  Lancet       Date:  1988-11-05       Impact factor: 79.321

4.  Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

Authors:  F R Rickles; R L Edwards
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

Review 5.  Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Authors:  N I Weijl; M F Rutten; A H Zwinderman; H J Keizer; M A Nooy; F R Rosendaal; F J Cleton; S Osanto
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

6.  Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case report.

Authors:  Max Senna Mano; José Luiz Miranda Guimarães; Sören Franz Marian Chicata Sutmöller; André Borba Reiriz; Christian Sandor Svend Chicata Sutmöller; Angelo Di Leo
Journal:  Sao Paulo Med J       Date:  2006-11-07       Impact factor: 1.044

7.  Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.

Authors:  N W Lemmers; M E Gels; D T Sleijfer; J T Plukker; W T van der Graaf; Z J de Langen; J H Droste; H S Koops; H J Hoekstra
Journal:  J Clin Oncol       Date:  1996-11       Impact factor: 44.544

8.  Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors:  Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.

Authors:  Janusz Rak; Chloe Milsom; Linda May; Petr Klement; Joanne Yu
Journal:  Semin Thromb Hemost       Date:  2006-02       Impact factor: 4.180

10.  The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.

Authors:  A-C Piketty; A Fléchon; A Laplanche; E Nouyrigat; J-P Droz; C Théodore; K Fizazi
Journal:  Br J Cancer       Date:  2005-10-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.